Back to marketplace
VEEDACLINICALRESEARCHUNLIST· ISIN INE01HQ01026· Ahmedabad, Gujarat, India· Est. 2004 Verified

Veeda Clinical Research Limited

Pharmaceuticals
420+0.00%

vs. prev. close ₹420

52W High

₹420

52W Low

₹415

Price History

52W High

₹420

52W Low

₹415

About Veeda Clinical Research Limited

Get the latest Veeda Clinical Research unlisted share price. Buy or sell Veeda Clinical Research with ease, stay updated with UnlistedZone.

About the Company Veeda Clinical Research Limited is one of the largest independent full-service clinical research organizations (CRO) in India. Established in 2004, the company has grown significantly, providing a broad range of clinical research solutions to the pharmaceutical industry globally. Business Model Veeda operates on a comprehensive business model offering end-to-end clinical research services, including pre-clinical, early phase, and late phase clinical trials. The company's approach is designed to deliver cost-effective and timely research solutions to pharmaceutical companies, thereby aiding in the development and launch of new drugs. Services Veeda offers a wide array of services that cover most aspects of drug development and launch. These include: Bioavailability and Bioequivalence (BA & BE) Studies: Specialized services to determine the pharmacokinetic properties of drugs. Pre-Clinical and Clinical Trials: Comprehensive services for conducting pre-clinical, Phase I, Phase II, and Phase III trials. Bioanalytical Services: Advanced bioanalytical research capabilities to support drug development. Pharmacovigilance: Safety monitoring and regulatory compliance services. Medical Writing: Preparation of essential study documents in line with regulatory requirements. Industry Trend The global CRO market is projected to grow significantly, driven by increasing pharmaceutical R&D expenditures and the outsourcing trend among pharmaceutical companies to reduce costs and expedite drug development. Veeda is well-positioned to capitalize on these trends with its extensive service offerings and strong regulatory compliance record. Branches and Research Facilities: Veeda has expanded its infrastructure to include multiple facilities: Ahmedabad: Four facilities with a total capacity of 532 beds and advanced bioanalytical laboratories. Mehsana: One clinical facility. Bangalore: Two pre-clinical facilities acquired through Bioneeds, featuring 99 exclusive experimen

Company Details

Industry

Pharmaceuticals

Founded

2004

Headquarters

Ahmedabad, Gujarat, India

Min Lot Size

1

Face Value

₹2.00

Total Shares

69858503

Regulatory Information

Corporate Identity Number (CIN)

U73100GJ2004PLC044023

PAN Number

AACCC3633Q

ISIN

INE01HQ01026

Key Valuation Ratios

As of FY2026 Annual · updated 07 Sept 2026Derived

Valuation

Market Cap

₹2,934.06 Cr

P/E Ratio

Not meaningful — loss-making

P/S Ratio

4.10×

P/B Ratio

2.62×

EV / EBITDA

14.12×

Returns & Per Share

ROE

-1.25%

EPS

₹-2.01

Book Value / Share

₹160.39

Solvency

Debt / Equity

0.38×

Interest Coverage

1.12×

Company Fundamentals

As of FY2026 Annual · updated 07 Sept 2026

Gross Profit

₹677.93 Cr

EBITDA

₹226.27 Cr

Revenue Growth

17.35%

Profit Margin

-1.96%

Express buy interest

No commitment — the desk will reach out

Current Price

420
+0.00%
Min lot: 1
Price/share420
Quantity100
Estimated Total42,000

Secure & Verified Transaction

Unlisted shares are illiquid and carry higher market risks. Please read the Risk Disclosure before investing.

Talk to a Specialist

Get expert guidance on this investment

52 Week Range
415
420
Chat with us